NEW DELHI: Piramal Healthcare Ltd is eyeing acquisitions in the US and Europe, and expects growth in business during the current fiscal year to
remain same as that in FY09, a senior official said on Wednesday. "We expect to buy 2-3 companies in advanced markets like the US and Europe," Swati Piramal, director, Piramal Healthcare told reporters. "The company expects the same level of growth as witnessed in the last fiscal," she said, adding the firm plans to add 300-400 professionals in the super-speciality marketing division. She ruled out any proposal to sell stake in Piramal Healthcare or Piramal Life Sciences Ltd.